A Multicenter, Open, Prospective Study to Evaluate the Safety and Efficacy of Leuprorelin Acetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Leuprorelin (Primary)
- Indications Precocious puberty
- Focus Therapeutic Use
Most Recent Events
- 29 May 2020 Status changed from not stated to completed.
- 09 Oct 2019 New trial record